Virginia Cancer Specialists

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia2 trials
• Chronic myeloid leukaemia1 trial
• Diffuse large B-cell lymphoma1 trial
• Follicular lymphoma1 trial

Phase

• Phase 33 trials
• Phase 11 trial
• Phase 21 trial

Status

• Active, not recruiting4 trials
• Completed1 trial

Lead sponsor

• ADC Therapeutics S.A.1 trial
• Biomea Fusion Inc.1 trial
• Epizyme, Inc.1 trial
• Novartis Pharmaceuticals1 trial
• Sellas Life Sciences Group1 trial

Running trials

• Active, not recruiting

  Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia

  NCT05384587· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2

  NCT04229979· Phase 3· Sellas Life Sciences Group· Source

• Active, not recruiting

  Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  NCT04384484· Phase 3· ADC Therapeutics S.A.· Source

• Active, not recruiting

  A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

  NCT04224493· Phase 3· Epizyme, Inc.· Source

Closed trials

• Completed

  A Phase 1 Study of BMF-500 in Adults With Acute Leukemia

  NCT05918692· Phase 1· Biomea Fusion Inc.· Source